Biotalys Reports Half-Year 2026 Financial Results & Business Highlights

Company Provides R&D UpdateGhent, BELGIUM, Aug. 20, 2026 (GLOBE NEWSWIRE) — Press release – regulated information Made substantial regulatory progress in both the U.S. and E.U. with first protein-based biocontrol EVOCA®, paving the regulatory pathway for its commercial version EVOCA NG Achieved promising results in field trials with a second lead BioFun-6 candidate from the AGROBODY® technology platform Entered into a strategic partnership with 21st.BIO, a leading precision fermentation technolRead More